feed,title,long_url,short_url
Benzinga,Theravance Biopharma Stock Drops After Nezulcitinib Disappoints In COVID-19 Study,https://benzinga.com/general/biotech/21/06/21640802/theravance-biopharma-stock-drops-after-nezulcitinib-disappoints-in-covid-19-study,https://j.mp/3iXLWHt
